According to the research report titled ‘Global Defibrillator Market - Analysis By Product Type, Patient Age, End User, By Region, By Country Market Insights, Covid-19 Impact, Competition and Forecast (2020-2025)’, available with Market Study Report, global defibrillator market was appraised at USD 10.71 billion in 2019 and likely to record a y-o-y growth rate of 3.59% between 2020 and 2025.
 

Growing elderly population and high prevalence of cardiovascular diseases are some of the key factors driving the growth of global defibrillator market. Technological breakthroughs in this industry vertical has allowed for development of easy to use defibrillators and has reduced the death rate in case of cardiac arrests, which in turn is aiding towards the market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2945328/
 

As per product type, the implantable segment is expected to generate lucrative returns for global defibrillator market in the ensuing years. Improving cognizance and growing demand for defibrillators in order to reduce the death rate during cardiac arrests have fueled the demand for implantable defibrillators, thereby stimulating the overall industry outlook.
 

Citing the end-user spectrum, global defibrillator market share from healthcare units is predicted to expand considerably during the forecast period. Growing demand for automatic external defibrillator in public places coupled with favorable regulatory outlook are favoring the overall market scenario.
 

From the regional point of view, North America is expected to stand tall in terms of revenue hierarchy in the overall market by the year 2025.
 

St. Jude Medical Inc., Fukuda Colin Co. Ltd., Nanoom Tech Co. Ltd., Koninklijke Philips N.V., LivaNova plc, Nihon Kohden Corporation, Biotronik, Boston Scientific Corporation, Medtronic plc, and Mindray Medical International Ltd. are the major companies operating in global defibrillator market.